Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
Parents today are generally aware of mental health conditions that relate to body image, including common disorders like ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...
The Fed’s preferred inflation gauge advanced 0.3%%. That was the biggest monthyly gain in eight months. AFP via Getty Images The policy statement accompanying the decision did not include the ...
immediately vaulting to the top of their respective weight classes (138 and 215) as well. With the team state tournament cutoff this weekend as well, there are plenty of new faces in the rankings ...
Hallmark symptoms of Cushing disease, including abdominal striae and facial rounding, were more common among younger patients than older patients.
Its etiology is common with that of clinical hypothyroidism; clinical symptoms most often include weight gain and fatigue. Subclinical forms of hypothyroidism are of increasing interest ...
Here’s what is proposed. For individuals, the inclusion rate is either 50% or 66.67%, depending on the size of the capital gain. With the current federal and provincial/territorial tax rates in ...
The rate rose 0.7 percent year-over-year in April, a $6 gain to $1,725, up $12 year-to-date and just $2 off the all-time high set last summer. National occupancy remained at 94.5 percent in March ...
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.